Arachidonic acid (AA) is a 20-carbon polyunsaturated fatty acid with four cis-double bonds, making it a highly flexible component within cellular environments. It is derived from dietary sources like meat, poultry, fish, and eggs, and is integrated into the phospholipids of cell membranes.
This integration is crucial as it affects membrane fluidity and the function of membrane-bound enzymes and receptors. AA's role extends beyond structural support, participating in the Lands cycle to maintain low free AA levels while providing a reservoir for metabolism into eicosanoids.
These eicosanoids, produced via cyclooxygenase and lipoxygenase pathways, are vital in regulating inflammation, immune responses, and homeostasis.
However, while AA has potential benefits in cognitive function, high concentrations can promote inflammation, highlighting the importance of balanced intake and metabolism for overall health.
Arachidonic Acid is a 20-carbon fatty acid characterized by four cis-double bonds, making it highly flexible and interactive within cellular environments.
It is primarily derived from dietary linoleic acid and is a crucial component of phospholipids in cell membranes. This structural role is fundamental, as it affects membrane fluidity and the functioning of membrane-bound enzymes and receptors.
As a polyunsaturated fatty acid, arachidonic acid (AA) plays an indispensable role in the structure and function of cell membranes.
Arachidonic acid is primarily obtained from dietary sources like poultry, meat, fish, and eggs. Once consumed, AA is incorporated into phospholipids within the cell's cytosol, adjacent to the endoplasmic reticulum where phospholipid synthesis occurs.
Integrated into these membrane phospholipids, typically at the sn-2 position of the glycerol backbone, AA contributes to the fluidity and flexibility of cellular membranes.
Its unique structure, with multiple double bonds, allows AA to impart a degree of fluidity that is crucial for the proper functioning of membrane-bound enzymes, receptors, and the overall integrity of cells and organelles.
However, AA's role in membranes extends beyond just structural support. It participates in the Lands cycle, a continuous reacylation and deacylation process that helps maintain low levels of free AA within cells while allowing its release from membranes when needed for metabolic purposes. [6., 12.]
This dynamic cycle ensures that AA not only serves as a structural component but also as a readily available reservoir for its subsequent metabolism into potent bioactive compounds called eicosanoids.
Arachidonic acid participates in complex metabolic processes within the body. This involves several enzymatic pathways that transform AA into a diverse array of bioactive compounds known as eicosanoids. The cyclooxygenase (COX) and lipoxygenase (LOX) pathways play a central role in this metabolic conversion.
Eicosanoids are a class of cellular signaling molecules derived from polyunsaturated fatty acids like arachidonic acid that play important roles in various physiological processes such as inflammation, immunity, and homeostasis.
Through the cyclooxygenase pathways, arachidonic acid is preferentially metabolized by the COX-2 enzyme into prostacyclin and prostaglandin E2 (PGE2).
These prostaglandins, along with thromboxanes like TXA2, are potent eicosanoid signaling molecules that exert profound effects on inflammation, blood clotting, and various homeostatic mechanisms within the body.
On the other hand, the lipoxygenase pathways convert arachidonic acid into leukotrienes, another class of eicosanoid mediators. These AA-derived eicosanoids from the COX and LOX pathways are crucial lipid mediators involved in numerous homeostatic and pathophysiological processes.
Leukotrienes such as LTB4, play pivotal roles in regulating inflammatory and immune responses by recruiting and activating leukocytes, the body's front-line defense cells.
The eicosanoids derived from arachidonic acid are remarkably versatile, regulating a wide range of physiological responses and pathological processes. They control critical cellular processes, including cell proliferation, apoptosis (programmed cell death), metabolism, and cell migration.
Regarding inflammation, eicosanoids exhibit both pro-inflammatory and anti-inflammatory roles, depending on the specific eicosanoid involved.
Notably, eicosanoids also modulate immune function, contributing to the inflammatory response while simultaneously generating mediators responsible for resolving inflammation and promoting wound healing. This delicate balance is essential for maintaining homeostasis within the body.
Furthermore, eicosanoids perform numerous regulatory functions throughout the body, particularly in the brain, where they play a crucial role in regulating immune and inflammatory responses. Their far-reaching effects underscore their significance in maintaining overall physiological equilibrium.
Arachidonic acid’s effects also involve the cardiovascular system. Arachidonic acid (AA) and its metabolites play important roles in modulating cardiovascular function under both physiological and pathological conditions.
AA metabolites like prostaglandins, prostacyclin, and thromboxanes are involved in regulating vascular tone, while others like hydroxyeicosatetraenoic acids and epoxyeicosatrienoic acids modulate processes like atherosclerosis and hypertension.
However, an imbalance in AA metabolite levels can contribute to the development of cardiovascular diseases like atherosclerosis and myocardial infarction.
Arachidonic Acid (AA) is often discussed in the context of its role in inflammatory processes, but a healthy amount of arachidonic acid also confers physiological benefits that are crucial for maintaining health.
In the brain, Arachidonic Acid is essential for cognitive and neural functions. It is a key component of neuronal cell membranes, affecting their fluidity and functioning.
AA-derived eicosanoids are involved in signaling pathways that support synaptic plasticity, which is crucial for learning and memory.
AA also plays a role in protecting neurons and assisting in the brain's response to injury, demonstrating its critical involvement in maintaining neural health.
Arachidonic Acid is also integral to the immune system.
It is involved in the production of eicosanoids that mediate various immune responses including the regulation of inflammation and the activation of immune cells. These eicosanoids ensure that the body's response to infection is swift and effective, helping to manage and resolve inflammatory responses appropriately.
AA also aids in the production of prostaglandins which play a role in fever and pain responses, further underscoring its importance in immune function.
Dietary Sources of Arachidonic Acid (AA) include:
While AA is an essential nutrient, it is crucial to maintain a balanced intake of omega-6 and omega-3 fatty acids in the diet.
The Dietary Guidelines for Americans 2020-2025 recommend a daily intake of 1.1-1.6 grams of omega-3 fatty acids for adults. [13.] However, there is no specific recommendation for omega-6 fatty acids, with the adequate intake being 17 grams for men and 12 grams for women aged 19-50 years, according to the Food and Nutrition Board of the U.S. Institute of Medicine.
Ideally, the ratio of omega-6 to omega-3 fatty acids should be around 4:1, meaning four parts omega-6 for every one part omega-3.
Unfortunately, the typical American diet deviates significantly from this recommended ratio. On average, Americans consume an omega-6 to omega-3 ratio ranging from 10:1 to 20:1, which is substantially higher than the ideal 4:1 ratio. [10.]
This imbalance is primarily due to the high consumption of omega-6-rich vegetable oils and processed foods, coupled with a low intake of omega-3-rich foods like fatty fish. Achieving a balanced ratio can be accomplished by increasing the intake of omega-3-rich foods and limiting sources of excessive omega-6s, such as fried foods and processed snacks.
By making conscious dietary choices and prioritizing a diverse range of nutrient-dense foods, individuals can ensure an optimal intake of these essential fatty acids and promote overall well-being.
Blood testing for Arachidonic Acid levels is commonly used to assess an individual's fatty acid profile and overall nutritional status. The procedure typically involves obtaining a small blood sample through venipuncture, commonly from a vein in the arm.
Increasingly, laboratory companies are also offering essential fatty acid analysis including arachidonic acid as a blood spot test, which can be done from the comfort of a patient’s home.
Fasting for a minimum of 12 hours is generally recommended, and certain medications or supplements may need to be avoided.
It is essential to consult with the laboratory company used for analysis of individual laboratory results.
One company expresses results as a percentage of an individual’s total essential fatty acid (EFA) levels present in red blood cells, reporting arachidonic acid levels with an optimal range of 9-19% of total EFAs. [9.]
Another company reports optimal levels of arachidonic acid as 7-12% total EFAs. [8.]
Elevated levels of arachidonic acid (AA) and a high AA/EPA ratio are significant indicators of an inflammatory state.
AA is a precursor to pro-inflammatory eicosanoids, playing a key role in inflammatory responses. Elevated AA can increase the production of tumor necrosis factor-beta, an anti-inflammatory mediator, but also raises the risk of heart disease.
A high AA/EPA ratio, common in diets rich in red meat and corn oil, signifies an imbalance between omega-6 and omega-3 fatty acids. This imbalance can inhibit the synthesis of omega-3 fatty acids, contributing to pro-inflammatory conditions.
Reducing the AA/EPA ratio through omega-3 supplementation, such as fish oils rich in EPA and DHA, can decrease inflammation and improve symptoms in conditions like ADHD and depression.
Typically, lower levels of arachidonic acid are preferred, as this represents a baseline anti-inflammatory physiological state. This is especially true in the setting of robust levels of omega-3 fatty acids including eicosapentaenoic acid, and a low AA/EPA ratio.
Arachidonic acid levels are often interpreted in the context of an individual’s wider essential fatty acid balance.
The Arachidonic Acid (AA) to Eicosapentaenoic Acid (EPA) ratio, known as the AA/EPA ratio, is a vital biomarker that reflects the body's balance of key omega-6 and omega-3 fatty acids. This ratio provides insights into dietary intake and is closely linked to numerous health outcomes, particularly those related to inflammation and cardiovascular health.
AA, an omega-6 fatty acid, is crucial for cellular signaling and inflammatory responses, serving as a precursor to pro-inflammatory eicosanoids.
Conversely, EPA, an omega-3 fatty acid, possesses anti-inflammatory properties and competes with AA in cell membrane incorporation and eicosanoid synthesis.
Maintaining a balanced AA/EPA ratio is essential as an imbalance, particularly a high AA/EPA ratio, can lead to a pro-inflammatory state, increasing the risk for chronic diseases such as cardiovascular disease.
Managing this ratio through diet, lifestyle changes, and supplementation can significantly impact overall health and inflammation levels.
For more information on the AA/EPA ratio, click here.
Alongside monitoring AA levels, assessing other related biomarkers can provide a more comprehensive view of an individual's health status, particularly concerning inflammation and cardiovascular risk.
The Omega-3 Index is a test that measures the percentage of EPA and DHA (docosahexaenoic acid) in red blood cell membranes. This index is a reliable indicator of an individual's omega-3 status and has been linked to the risk of heart disease. [3.]
A higher Omega-3 Index is associated with a reduced risk of sudden cardiac death and other adverse cardiovascular outcomes. By analyzing this alongside the AA/EPA ratio, healthcare providers can gain valuable insights into a patient’s fatty acid balance and cardiovascular health.
Another important biomarker to consider is the triglycerides to HDL (high-density lipoprotein) cholesterol ratio. This ratio is a marker of lipid metabolism and cardiovascular health, and an important example of the connection between blood sugar and lipid levels in cardiometabolic disorders. [4.]
High levels of triglycerides coupled with low levels of HDL cholesterol are linked to an increased risk of atherosclerosis and heart disease. [4.] This ratio can provide additional information on cardiovascular risk, especially when considered in conjunction with the AA/EPA ratio.
High Sensitivity C-Reactive Protein is a marker of inflammation in the body. High levels of hsCRP are associated with various conditions, including cardiovascular disease and inflammatory diseases.
By measuring hsCRP levels, healthcare providers can assess the level of systemic inflammation, which can be a crucial factor in understanding the implications of an imbalanced AA/EPA ratio. [2.]
[1.] Arachidonic Acid | Peer Reviewed Journals. www.longdom.org. Accessed May 16, 2024. https://www.longdom.org/peer-reviewed-journals/arachidonic-acid-19976.html
[2.] Fonseca FA, Izar MC. High-Sensitivity C-Reactive Protein and Cardiovascular Disease Across Countries and Ethnicities. Clinics (Sao Paulo). 2016 Apr;71(4):235-42. doi: 10.6061/clinics/2016(04)11. PMID: 27166776; PMCID: PMC4825196.
[3.] Harris WS. The omega-3 index: clinical utility for therapeutic intervention. Curr Cardiol Rep. 2010 Nov;12(6):503-8. doi: 10.1007/s11886-010-0141-6. PMID: 20809235.
[4.] Kosmas CE, Rodriguez Polanco S, Bousvarou MD, Papakonstantinou EJ, Peña Genao E, Guzman E, Kostara CE. The Triglyceride/High-Density Lipoprotein Cholesterol (TG/HDL-C) Ratio as a Risk Marker for Metabolic Syndrome and Cardiovascular Disease. Diagnostics (Basel). 2023 Mar 1;13(5):929. doi: 10.3390/diagnostics13050929. PMID: 36900073; PMCID: PMC10001260.
[5.] National Institute of Health. Office of Dietary Supplements - Omega-3 Fatty Acids. Nih.gov. Published February 15, 2023. https://ods.od.nih.gov/factsheets/Omega3FattyAcids-HealthProfessional/
[6.] Pérez R, Matabosch X, Llebaria A, Balboa MA, Balsinde J. Blockade of arachidonic acid incorporation into phospholipids induces apoptosis in U937 promonocytic cells. J Lipid Res. 2006 Mar;47(3):484-91. doi: 10.1194/jlr.M500397-JLR200. Epub 2005 Dec 2. PMID: 16326977.
[7.] Roberts BM, Kolb AL, Geddis AV, Naimo MA, Matheny RW. The dose-response effects of arachidonic acid on primary human skeletal myoblasts and myotubes. J Int Soc Sports Nutr. 2023 Jan 3;20(1):2164209. doi: 10.1080/15502783.2022.2164209. PMID: 36620755; PMCID: PMC9817121.
[8.] Rupa Health. 1.Essential and Metabolic Fatty Acids Bloodspot Sample Report.pdf. Google Docs. Accessed May 16, 2024. https://drive.google.com/file/d/1AVhrP4Pu97xNWTGhRL7BleVI0V1l4wMr/view
[9.] Rupa Health. 1.Fatty Acids Sample Report.pdf. Google Docs. Accessed May 16, 2024. https://drive.google.com/file/d/1YDrbhHLYGGDGmqiwnPQMls8hbytd-l8v/view
[10.] Simopoulos AP. The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Experimental biology and medicine (Maywood, NJ). 2008;233(6):674-688. doi:https://doi.org/10.3181/0711-MR-311
[11.] Sonnweber T, Pizzini A, Nairz M, Weiss G, Tancevski I. Arachidonic Acid Metabolites in Cardiovascular and Metabolic Diseases. Int J Mol Sci. 2018 Oct 23;19(11):3285. doi: 10.3390/ijms19113285. PMID: 30360467; PMCID: PMC6274989.
[12.] Tallima H, El Ridi R. Arachidonic acid: Physiological roles and potential health benefits - A review. J Adv Res. 2017 Nov 24;11:33-41. doi: 10.1016/j.jare.2017.11.004. PMID: 30034874; PMCID: PMC6052655.
[13.] United States Department of Agriculture. Dietary Guidelines for Americans 2020 -2025 . USDA; 2020. https://www.dietaryguidelines.gov/sites/default/files/2020-12/Dietary_Guidelines_for_Americans_2020-2025.pdf
[14.] Wang, B., Wu, L., Chen, J. et al. Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets. Sig Transduct Target Ther 6, 94 (2021). https://doi.org/10.1038/s41392-020-00443-w
[15.] Yui K, Imataka G, Nakamura H, Ohara N, Naito Y. Eicosanoids Derived From Arachidonic Acid and Their Family Prostaglandins and Cyclooxygenase in Psychiatric Disorders. Curr Neuropharmacol. 2015;13(6):776-85. doi: 10.2174/1570159x13666151102103305. PMID: 26521945; PMCID: PMC4759316.
[16.] Zhou Y, Khan H, Xiao J, Cheang WS. Effects of Arachidonic Acid Metabolites on Cardiovascular Health and Disease. Int J Mol Sci. 2021 Nov 6;22(21):12029. doi: 10.3390/ijms222112029. PMID: 34769460; PMCID: PMC8584625.